IL184417A - Method for analyzing oligosaccharides from blood plasma - Google Patents

Method for analyzing oligosaccharides from blood plasma

Info

Publication number
IL184417A
IL184417A IL184417A IL18441707A IL184417A IL 184417 A IL184417 A IL 184417A IL 184417 A IL184417 A IL 184417A IL 18441707 A IL18441707 A IL 18441707A IL 184417 A IL184417 A IL 184417A
Authority
IL
Israel
Prior art keywords
concentrate
oligosaccharide
saline solution
solution
plasma
Prior art date
Application number
IL184417A
Other languages
English (en)
Other versions
IL184417A0 (en
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL184417A0 publication Critical patent/IL184417A0/en
Publication of IL184417A publication Critical patent/IL184417A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8822—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8836—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving saccharides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL184417A 2005-01-19 2007-07-04 Method for analyzing oligosaccharides from blood plasma IL184417A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0500554A FR2880951B1 (fr) 2005-01-19 2005-01-19 Methode d'analyse d'oligosaccharides a partir de plasma sanguin
PCT/FR2006/000112 WO2006077317A1 (fr) 2005-01-19 2006-01-18 Methode d'analyse d'oligosaccharides a partir de plasma sanguin

Publications (2)

Publication Number Publication Date
IL184417A0 IL184417A0 (en) 2007-10-31
IL184417A true IL184417A (en) 2011-10-31

Family

ID=35385848

Family Applications (1)

Application Number Title Priority Date Filing Date
IL184417A IL184417A (en) 2005-01-19 2007-07-04 Method for analyzing oligosaccharides from blood plasma

Country Status (14)

Country Link
US (1) US7575930B2 (de)
EP (1) EP1842070B1 (de)
JP (1) JP5203714B2 (de)
KR (1) KR20070103387A (de)
CN (1) CN101107526B (de)
AR (1) AR051905A1 (de)
AU (1) AU2006207440B2 (de)
BR (1) BRPI0606619B1 (de)
CA (1) CA2591631A1 (de)
FR (1) FR2880951B1 (de)
IL (1) IL184417A (de)
MX (1) MX2007008791A (de)
RU (1) RU2415436C2 (de)
WO (1) WO2006077317A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
US7968082B1 (en) 2007-01-26 2011-06-28 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by NMR
US7790466B1 (en) * 2007-01-26 2010-09-07 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2256138A1 (de) * 2009-05-05 2010-12-01 Sanofi-Aventis Neues acyliertes 1,6-anhydrodecasacharid und seine Verwendung als antithrombitisches Mittel
EP2526122B1 (de) * 2010-01-19 2020-06-10 Momenta Pharmaceuticals, Inc. Beurteilung von heparinzubereitungen
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2020252677A1 (zh) * 2019-06-19 2020-12-24 北京三元食品股份有限公司 乳中游离低聚糖的高通量定量测定方法
CN115112799B (zh) * 2022-06-30 2023-02-28 北京三元食品股份有限公司 一种定性检测母乳中酸性低聚糖的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702254D0 (sv) * 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
JPH02227144A (ja) * 1989-02-28 1990-09-10 Asahi Chem Ind Co Ltd 陰イオン交換体及びそれを充填した糖類分離用液体クロマトグラフィー用カラム
US5843786A (en) * 1995-11-28 1998-12-01 Neose Technologies, Inc. Analysis of carbohydrates in biological fluids by high performance liquid chromatography
US6291439B1 (en) * 1998-09-02 2001-09-18 Biomarin Pharmaceuticals Methods for diagnosing atherosclerosis by measuring endogenous heparin and methods for treating atherosclerosis using heparin
US6617316B1 (en) * 1999-10-22 2003-09-09 Aventis Pharma Oligosaccharides, their preparation and pharmaceutical compositions containing them
JP4828795B2 (ja) * 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
JP4373917B2 (ja) * 2002-09-23 2009-11-25 アベンティス・ファーマ・ソシエテ・アノニム ヘパリンを形成している特異基の測定方法
FR2844808B1 (fr) * 2002-09-23 2005-02-25 Aventis Pharma Sa Methode de determination de groupements specifiques constituant les heparines ou les heparines de bas poids moleculaire
US20040265943A1 (en) * 2002-09-23 2004-12-30 Aventis Pharma S.A. Method for quantitatively determining specific groups constituting heparins or low molecular weight heparins

Also Published As

Publication number Publication date
CN101107526B (zh) 2013-08-14
IL184417A0 (en) 2007-10-31
EP1842070B1 (de) 2016-04-13
MX2007008791A (es) 2007-09-11
BRPI0606619A2 (pt) 2009-07-07
JP5203714B2 (ja) 2013-06-05
CA2591631A1 (fr) 2006-07-27
AU2006207440B2 (en) 2011-04-21
EP1842070A1 (de) 2007-10-10
JP2008527390A (ja) 2008-07-24
RU2415436C2 (ru) 2011-03-27
KR20070103387A (ko) 2007-10-23
FR2880951A1 (fr) 2006-07-21
FR2880951B1 (fr) 2015-09-18
WO2006077317A1 (fr) 2006-07-27
BRPI0606619B1 (pt) 2016-12-13
AU2006207440A1 (en) 2006-07-27
CN101107526A (zh) 2008-01-16
AR051905A1 (es) 2007-02-14
US20080009069A1 (en) 2008-01-10
US7575930B2 (en) 2009-08-18
RU2007131442A (ru) 2009-02-27

Similar Documents

Publication Publication Date Title
US7575930B2 (en) Method for analyzing oligosaccharides from blood plasma
EP1730200B1 (de) Verfahren zur quantitativen Bestimmung von spezifischen Gruppen von Heparinen oder niedermolekularen Heparinen mittels HPLC
Hardy et al. [6] Separation of oligosaccharides using high-performance anion-exchange chromatography with pulsed amperometric detection
Jones et al. Heparin characterization: challenges and solutions
EP2314632B1 (de) Aus Heparin abgeleitete Oligosaccharide
Brustkern et al. Characterization of currently marketed heparin products: reversed-phase ion-pairing liquid chromatography mass spectrometry of heparin digests
JP6208866B2 (ja) 硫酸化オリゴ糖を検出する分析法
US8252597B1 (en) Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
EP2697265B1 (de) Polysaccharide mit zwei antithrombin iii-bindungsstellen, ihre herstellung und ihre verwendung als antithrombotika
Patel et al. Effective reversed-phase ion pair high-performance liquid chromatography method for the separation and characterization of intact low-molecular-weight heparins
US20040265943A1 (en) Method for quantitatively determining specific groups constituting heparins or low molecular weight heparins
Nagasawa et al. Chemical change involved in the oxidative-reductive depolymerization of heparin
CN109596742B (zh) 一种检测硫酸乙酰肝素成品中主要成分含量的方法
KR101552591B1 (ko) 당 사슬 조성 분석 방법
Chmielewski et al. The use of SAX-HPLC–CD as a heparin screening strategy
Gándara-Mireles et al. A new validated method for the quantification of Doxorubicin in plasma by High Performance Liquid Chromatography (HPLC) with application in pharmacokinetic studies: quantification of Doxorubicin by HPLC in pharmacokinetic studies
Kavitha et al. A pH-GRADIENT SAX-HPLC METHOD FOR DETERMINATION OF TRACE LEVELS OF OVER SULFATED CHONDROITIN SULFATE AND DERMATAN SULFATE IN HEPARIN SODIUM
Henshall High-performance liquid chromatography techniques used in dietary fiber and complex carbohydrates analysis
Stanley III Advancing Modern Forensic Investigations Through The Use of Various Analytical Techniques
Seada et al. Application of Multi-criteria Decision Making Approach and Experimental Design and Development of Stability-indicating UPLC Method for Simultaneous Determination of Losartan Potassium and Hydrochlorothiazide in Bulk and Tablet Dosage Form
MXPA06010455A (es) Metodo para determinar cuantitativamente los especificos que constituyen heparinas o las heparinas de bajo peso molecular usando hplc

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees